Obesity Control
-
{
- All
- News
- Videos
- Web Stories
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Doctor Explains How Ashwagandha May Reduce Belly Fat Linked To Stress
Dr Manish Shetty explains how Ashwagandha supplementation can be used to reduce belly fat caused by stress. There are also potential side effects that may affect its properties.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
-
Eat Same Meals Daily? Study Says It May Help You Lose Weight Faster
A study finds that eating the same meals regularly and maintaining consistent calorie intake may help people lose more weight, highlighting the importance of simple and structured eating habits.
-
ICMR-NIN Develops Herbal Formulation To Tackle Diabetes, Obesity
The ICMR-National Institute of Nutrition has developed a poly-herbal extract that goes beyond blood sugar control to target complications linked to diabetes and obesity, including kidney damage, vision loss, and nerve disorders.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Is Bariatric Surgery Too Extreme? Surgeon Explains Why This Obesity Treatment Still Matters
Bariatric surgery is called extreme far more often than obesity itself is. That imbalance reflects how this condition is still viewed, by the public and, at times, even within medicine.
-
How Python Blood Molecule Could Help Fight Obesity, Scientists Say
A molecule found in python blood has shown the ability to reduce appetite and promote weight loss in mice, offering potential for new obesity treatments.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Doctor Explains How Ashwagandha May Reduce Belly Fat Linked To Stress
Dr Manish Shetty explains how Ashwagandha supplementation can be used to reduce belly fat caused by stress. There are also potential side effects that may affect its properties.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
-
Eat Same Meals Daily? Study Says It May Help You Lose Weight Faster
A study finds that eating the same meals regularly and maintaining consistent calorie intake may help people lose more weight, highlighting the importance of simple and structured eating habits.
-
ICMR-NIN Develops Herbal Formulation To Tackle Diabetes, Obesity
The ICMR-National Institute of Nutrition has developed a poly-herbal extract that goes beyond blood sugar control to target complications linked to diabetes and obesity, including kidney damage, vision loss, and nerve disorders.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Is Bariatric Surgery Too Extreme? Surgeon Explains Why This Obesity Treatment Still Matters
Bariatric surgery is called extreme far more often than obesity itself is. That imbalance reflects how this condition is still viewed, by the public and, at times, even within medicine.
-
How Python Blood Molecule Could Help Fight Obesity, Scientists Say
A molecule found in python blood has shown the ability to reduce appetite and promote weight loss in mice, offering potential for new obesity treatments.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
